Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model

Metabolism: Clinical and Experimental

Volumn 59, Issue 8, 2010, Pages 1092-1105

  De Meijer, Vincent E ^a,b   Le, Hau D ^a   Meisel, Jonathan A ^a   Sharif, M Reza Akhavan ^c   Pan, Amy ^a   Nosé, Vânia ^d   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; ACYL COENZYME A DESATURASE; ALANINE AMINOTRANSFERASE; SCD1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT CONTENT; FAT INTAKE; FATTY ACID TRANSPORT; FATTY LIVER; FEEDING; GENE EXPRESSION; HYPOTHESIS; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER INJURY; MALE; METABOLIC SYNDROME X; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WEIGHT GAIN; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; GENETICS; HYPERPHAGIA; LIVER; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGAN SIZE;

ALANINE TRANSAMINASE; ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FATTY LIVER; HYPERPHAGIA; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; WEIGHT GAIN;

EID: 77955500907     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.11.006     Document Type: Article

References (44)

1. Angulo P. Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
2. Powell E.E., Cooksley W.G., and Hanson R. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
3. Teli M.R., James O.F., and Burt A.D. The natural history of nonalcoholic fatty liver: a follow-up study Hepatology 22 1995 1714 1719
4. Browning J.D., Szczepaniak L.S., and Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
5. Bellentani S., Saccoccio G., and Masutti F. Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117
6. Fan C.Y., Pan J., and Usuda N. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism J Biol Chem 273 1998 15639 15645
7. Nomura H., Kashiwagi S., and Hayashi J. Prevalence of fatty liver in a general population of Okinawa, Japan Jpn J Med 27 1988 142 149
8. Ratziu V., Giral P., and Charlotte F. Liver fibrosis in overweight patients Gastroenterology 118 2000 1117 1123
9. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
10. Clark J.M., and Diehl A.M. Hepatic steatosis and type 2 diabetes mellitus Curr Diab Rep 2 2002 210 215
11. Marchesini G., Brizi M., and Bianchi G. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
12. Collins S., Martin T.L., and Surwit R.S. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics Physiol Behav 81 2004 243 248
13. Petro A.E., Cotter J., and Cooper D.A. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse Metabolism 53 2004 454 457
14. Brownlow B.S., Petro A., and Feinglos M.N. The role of motor activity in diet-induced obesity in C57BL/6J mice Physiol Behav 60 1996 37 41
15. Parekh P.I., Petro A.E., and Tiller J.M. Reversal of diet-induced obesity and diabetes in C57BL/6J mice Metabolism 47 1998 1089 1096
16. Howard B.V., Manson J.E., and Stefanick M.L. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial JAMA 295 2006 39 49
17. Astrup A. Dietary management of obesity JPEN J Parenter Enteral Nutr 32 2008 575 577
18. Sacks F.M., Bray G.A., and Carey V.J. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates N Engl J Med 360 2009 859 873
19. Tuomilehto J., Lindstrom J., and Eriksson J.G. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350 (Pubitemid 32378388)
20. Reeves P.G., Nielsen F.H., and Fahey G.C. Jr AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet J Nutr 123 1993 1939 1951
21. Hermanowski-Vosatka A., Balkovec J.M., and Cheng K. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice J Exp Med 202 2005 517 527
22. Muniyappa R., Lee S., and Chen H. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 2008 E15 E26
23. Alwayn I.P., Andersson C., and Lee S. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model Am J Physiol Gastrointest Liver Physiol 291 2006 G1011 G1019
24. Popov Y., Patsenker E., and Fickert P. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J Hepatol 43 2005 1045 1054
25. Donnelly K.L., Smith C.I., and Schwarzenberg S.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
26. Harrison S.A., and Day C.P. Benefits of lifestyle modification in NAFLD Gut 56 2007 1760 1769
27. Koteish A., and Diehl A.M. Animal models of steatosis Semin Liver Dis 21 2001 89 104
28. Musso G., Gambino R., and De Michieli F. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis Hepatology 37 2003 909 916
29. Tiikkainen M., Bergholm R., and Vehkavaara S. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content Diabetes 52 2003 701 707
30. Flowers M.T., and Ntambi J.M. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism Curr Opin Lipidol 19 2008 248 256
31. Sampath H., Miyazaki M., and Dobrzyn A. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat J Biol Chem 282 2007 2483 2493
32. Li Z.Z., Berk M., and McIntyre T.M. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase J Biol Chem 284 2009 5637 5644
33. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109 2002 1125 1131
34. Hotamisligil G.S. Inflammation and metabolic disorders Nature 444 2006 860 867
35. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus J Biol Chem 274 1999 30028 30032
36. Matsuzaka T., Shimano H., and Yahagi N. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance Nat Med 13 2007 1193 1202
37. Hillgartner F.B., Salati L.M., and Goodridge A.G. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis Physiol Rev 75 1995 47 76
38. Bellentani S., Dalle Grave R., and Suppini A. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach Hepatology 47 2008 746 754
39. Zivkovic A.M., German J.B., and Sanyal A.J. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am J Clin Nutr 86 2007 285 300
40. Wilsey J., Zolotukhin S., and Prima V. Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity Am J Physiol Regul Integr Comp Physiol 285 2003 R1011 R1020
41. Piers L.S., Walker K.Z., and Stoney R.M. The influence of the type of dietary fat on postprandial fat oxidation rates: monounsaturated (olive oil) vs saturated fat (cream) Int J Obes Relat Metab Disord 26 2002 814 821
42. Wang D., Wei Y., and Pagliassotti M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis Endocrinology 147 2006 943 951 (Pubitemid 43113013)
43. Laaksonen D.E., Nyyssonen K., and Niskanen L. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids Arch Intern Med 165 2005 193 199
44. Townsend K.L., Lorenzi M.M., and Widmaier E.P. High-fat diet-induced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice Endocrine 33 2008 176 188